TY - JOUR
T1 - Treatment of stage IVA hepatocellular carcinoma
T2 - Should we reappraise the role of surgery?
AU - Chirica, Mircea
AU - Scatton, Olivier
AU - Massault, Pierre Philippe
AU - Aloia, Thomas
AU - Randone, Bruto
AU - Dousset, Bertrand
AU - Legmann, Paul
AU - Soubrane, Olivier
PY - 2008/6
Y1 - 2008/6
N2 - Hypothesis: A subset of patients with stage IVA hepatocellular carcinoma (HCC) and preserved liver function may benefit from hepatic resection. Design: Retrospective review of a prospectively collected database. Setting: An academic tertiary care hepatobiliary unit. Patients: Twenty patients who underwent surgical treatment for stage IVA HCC between July 1998 and October 2004 were identified from the database. Intervention: Intraoperative ablation of HCC nodules was combined with resection in 6 patients (30%) to increase resectability. Three patients also underwent resection of extrahepatic tumors. Five patients (25%) had macroscopic invasion of the portal vein and 2 patients (10%) underwent thrombectomy of the vena cava. Main Outcome Measures: Intraoperative data, recurrence, and long-term survival rates were analyzed. Results: Postoperative mortality and morbidity were 5% and 30%, respectively. The median number of resected tumors per patient was 3, and the median diameter of the largest tumor was 60 mm. With a median follow-up of 23 months, 14 patients (70%) developed recurrence. Treatment of recurrence was possible in 10 patients and included transarterial chemoembolization in 7 patients (35%), of whom 2 (10%) had radiofrequency ablation first, and systemic chemotherapy in 3 patients (15%). Median survival time was 32 months, and the actuarial 1-, 3-, and 5-year survival rates were 73%, 56%, and 45%, respectively. Conclusions: Long-term survival can be achieved using an aggressive surgical approach in select patients with advanced HCC. Patients with stage IVA HCC should be followed up by a multidisciplinary team because recurrence is common and sequential treatments may prolong survival.
AB - Hypothesis: A subset of patients with stage IVA hepatocellular carcinoma (HCC) and preserved liver function may benefit from hepatic resection. Design: Retrospective review of a prospectively collected database. Setting: An academic tertiary care hepatobiliary unit. Patients: Twenty patients who underwent surgical treatment for stage IVA HCC between July 1998 and October 2004 were identified from the database. Intervention: Intraoperative ablation of HCC nodules was combined with resection in 6 patients (30%) to increase resectability. Three patients also underwent resection of extrahepatic tumors. Five patients (25%) had macroscopic invasion of the portal vein and 2 patients (10%) underwent thrombectomy of the vena cava. Main Outcome Measures: Intraoperative data, recurrence, and long-term survival rates were analyzed. Results: Postoperative mortality and morbidity were 5% and 30%, respectively. The median number of resected tumors per patient was 3, and the median diameter of the largest tumor was 60 mm. With a median follow-up of 23 months, 14 patients (70%) developed recurrence. Treatment of recurrence was possible in 10 patients and included transarterial chemoembolization in 7 patients (35%), of whom 2 (10%) had radiofrequency ablation first, and systemic chemotherapy in 3 patients (15%). Median survival time was 32 months, and the actuarial 1-, 3-, and 5-year survival rates were 73%, 56%, and 45%, respectively. Conclusions: Long-term survival can be achieved using an aggressive surgical approach in select patients with advanced HCC. Patients with stage IVA HCC should be followed up by a multidisciplinary team because recurrence is common and sequential treatments may prolong survival.
UR - http://www.scopus.com/inward/record.url?scp=45549083873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=45549083873&partnerID=8YFLogxK
U2 - 10.1001/archsurg.143.6.538
DO - 10.1001/archsurg.143.6.538
M3 - Article
C2 - 18559745
AN - SCOPUS:45549083873
SN - 0004-0010
VL - 143
SP - 538
EP - 543
JO - Archives of Surgery
JF - Archives of Surgery
IS - 6
ER -